News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CN Set to Optimize Volume-Based Procurement Rules, Strengthen Implementation of Results
Since 2018, China has carried out 11 batches of national-level centralized volume-based drug procurement, covering 490 drugs, said Shi Zihai, deputy head of the National Healthcare...
Reset
Send
The window will close in 5 seconds
CN Set to Optimize Volume-Based Procurement Rules, Strengthen Implementation of Results
Close
Recommend
58
Positive
97
Negative
37
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

Since 2018, China has carried out 11 batches of national-level centralized volume-based drug procurement, covering 490 drugs, said Shi Zihai, deputy head of the National Healthcare Security Administration (NHSA).

Going forward, the NHSA will focus on improving the price formation mechanism for centralized drug procurement in accordance with the recently issued opinions on improving this mechanism.

Related News M Stanley: Risk-Reward of China Biotech Stocks to Improve in 2H2026
Shi stressed that procurement rules will be optimized based on the characteristics of different categories of drugs, and efforts will be made to strengthen the implementation of selected procurement results.

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.